-
Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC
Source: Buzz FX / 07 Feb 2025 14:01:09 America/New_York
Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Immuneering ( NASDAQ:IMRX - Get Free Report ) 's stock had its "buy" rating restated by investmen
Read more...